GENE ONLINE|News &
Opinion
Blog

2017-11-07|

November 8, 2012: Completion of the Liver Cancer Genome

by GeneOnline
Share To
Blood tests for Alzheimer's disease essential for preventative screening, cheaper and less invasive alternative than PET scans or spinal taps.

Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death worldwide. The whole genome sequence of HCC was completed by RIKEN, a Japanese research institution, and was published on November 8, 2012. The result revealed many new cancer-associated genes, a variety of genomic alterations, and the common integration sites for hepatitis B virus (HBV) genome. The report was a step forward for studying the HBV virus and for developing new drugs for liver cancer.

Reference

https://www.ncbi.nlm.nih.gov/pubmed/23142287

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
The FDA Expands Use for Gilead Science’s HBV Treatment
2022-11-02
M&A
Xbiome Acquires Ulcerative Colitis Program from Assembly Biosciences
2022-04-29
R&D
Shionogi, NEC Team Up on Hepatitis B Vaccine
2022-04-20
LATEST
Preventive Medicine for Neurodegeneration on the Rise: New Breakthrough in Routine Blood Testing for Alzheimer’s Disease
2024-05-20
Discrimination Leads to Rapid Aging, Science Shows the Detrimental Effects of this Act
2024-05-17
A New Study has Linked Treatment Resistant Depression to Body Mass Index
2024-05-16
AI Reveals Sex-Related Brain Differences and Precision Medicine Potential
2024-05-16
The EU Sustainability Directive’s Influence on Pharmaceutical Supply Chains
2024-05-15
New UC Berkeley Study Challenges Traditional Views on Lactate and Carbohydrate Metabolism
2024-05-15
First Person to Receive Transplanted Pig Kidney has Died
2024-05-13
EVENT
Scroll to Top